VanEck Pharmaceutical ETF PPH
Set alert
119.21 USD -0.12 -0.10%
At close
118.36 -0.85 -0.71%
Pre-market · Nov 3, 7:24 AM ET
118.40 Day range 119.72
91.67 52-week range 120.86
- YTD
- +15.55%
- 1 year
- +28.40%
- Open
- 118.83
- Prev close
- 119.33
- Mkt cap
- 1.10B
- Vol
- 175.14K
- Avg vol
- 318.31K
- EPS
- 4.37
- P/E
- 27.25
- Div yield
- 0.00%
More statistics
- Low
- 118.40
- High
- 119.72
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 112.59
- 200-d avg
- 107.91
5D chart
Signals (111)
| Name | Time | Ago |
|---|---|---|
| MACD: Buy Signal | Nov 2, 2:35 PM | 17 hours ago |
| SMA: Bullish | Nov 2, 2:05 PM | 17 hours ago |
| SMA: Bullish | Nov 2, 2:05 PM | 17 hours ago |
| SMA: Bearish | Nov 2, 1:50 PM | 17 hours ago |
| MACD: Sell Signal | Nov 2, 1:45 PM | 18 hours ago |
| SMA: Bearish | Nov 2, 1:40 PM | 18 hours ago |
| SMA: Bullish | Nov 2, 12:55 PM | 18 hours ago |
| SMA: Bullish | Nov 2, 11:20 AM | 20 hours ago |
| SMA: Bearish | Nov 2, 11:10 AM | 20 hours ago |
| SMA: Bullish | Nov 2, 10:40 AM | 21 hours ago |
| MACD: Buy Signal | Nov 2, 10:40 AM | 21 hours ago |
| SMA: Bearish | Nov 2, 10:30 AM | 21 hours ago |
| SMA: Bullish | Nov 2, 10:20 AM | 21 hours ago |
| MACD: Sell Signal | Nov 2, 9:35 AM | 22 hours ago |
| RSI: Oversold | Nov 2, 9:35 AM | 22 hours ago |
| SMA: Bearish | Nov 2, 9:30 AM | 22 hours ago |
| MACD: Buy Signal | Oct 30, 3:55 PM | 3 days ago |
| SMA: Bullish | Oct 30, 3:45 PM | 3 days ago |
| RSI: Oversold | Oct 30, 3:25 PM | 3 days ago |
| SMA: Bearish | Oct 30, 2:20 PM | 3 days ago |
Newest 20 of 111.
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 27.25
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 112.59
- 200-day average
- 107.91
About VanEck Pharmaceutical ETF
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
News
- Can GLP-1s Fatten Your Portfolio? We Examine the VanEck Pharmaceutical ETF vs State Street SPDR Pharmaceuticals ETF
- PPH: Key Pharmaceutical Innovations Support Bullish Outlook (Upgrade)
- Two Years to Build or Pay 200% — Which US Pharma Stocks Win?
- Bristol-Myers Squibb-Anthropic AI Deal Targets Faster Drug Discovery
- What's Going On With Merck Stock Tuesday?
- Biotech ETF With A Twist: Defiance To Donate Initial Advisory Profits To Autism Causes
- Merck Inks AI Drug Discovery Deal With Mayo Clinic To Revolutionize Drug Discovery
- Trump Unveils 'Great Healthcare Plan,' Takes Aim At PBM 'Kickbacks'
- Novo Nordisk's Wegovy Pill Shakes Up Rivalry With Eli Lilly, Puts Health Care ETFs In Focus
- Novo Nordisk's Stock Slump Shows The GLP‑1 Trade's Side Effect: ETF Concentration Risk
Your note
Sign in to keep a note on PPH — it syncs with the Stock Master app.